BCBS Florida Medical Policy Updates – May 2018

Click here to view the Florida Blue Cross Blue Shield Medical Policy Updates »

May 2018 Medical Policy Updates:

• Agalsidase Beta (Fabrazyme®) IV
• Balloon Ostial Dilation (Balloon Sinuplasty) and Implantable Devices
• Brentuximab (Adcetris ®) Injection
• Cardiac Nuclear Imaging
• Clotting Factors and Coagulant Blood Products
• Colonografía por tomografía computarizada (TC) (Colonoscopia virtual)
• Computed Tomographic Angiography (CTA) Heart
• Computed Tomography (CT) Heart
• Computerized Axial Tomography (CT) Extremity (Upper and Lower)
• Corticosteroid Intravitreal Implant
• Eculizumab (Soliris®) Injection
• Enteral Formulas
• Ergotamine (Ergomar)
• Erythropoiesis Stimulating Agents
• Genetic Testing
• Growth Hormone Therapy
• Hydroxyprogesterone Caproate
• Investigational Services
• Ipilimumab (Yervoy TM) Injection
• Ivacaftor (Kalydeco TM) Oral
• Keratoplasty and Keratectomy
• Left Atrial Appendage Closure
• Lenalidomide (Revlimid®)
• Lumacaftor Ivacaftor (Orkambi TM) Capsule
• Magnetic Resonance Imaging (MRI) Cardiac
• Magnetic Resonance Imaging (MRI) Chest and Cardiac
• Magnetic Resonance Imaging Chest (Thorax)
• Medical and Surgical Management of Obstructive Sleep Apnea (OSA)
• Meniscal Allograft Transplantation
• Midostaurin (Rydapt)
• Multiple Gated Acquisition Scan (MUGA)
• Multiple Sclerosis Self Injectable Therapy
• Nilotinib (Tasigna®) Capsules
• Nivolumab (Opdivo)
• NK-1 receptor antagonist injectable therapy (Emend®, Cinvanti®, Varubi®)
• Non-Covered Services
• Obeticholic Acid (Ocaliva®) Tablet
• Obinutuzumab (Gazyva TM) Injection
• Oscillatory Devices for the Treatment of Cystic Fibrosis and Other Respiratory Disorders
• Palivizumab (Synagis®)
• Pasireotide (Signifor and Signifor LAR) Injection
• PCSK9 Inhibitors
• Pembrolizumab (Keytruda®) Injection
• Prophylactic Mastectomy
• Siltuximab (Sylvant TM) Injection
• Sodium Oxybate (Xyrem®) Oral
• Tocilizumab (Actemra®) Injection
• Total Ankle Replacement
• Tumor Genetic Markers
• Tumor Treatment Fields Therapy for Glioblastoma
• Vascular Endothelial Growth Factor Inhibitors for Ocular Neovascularization

Click here to view the Florida Blue Cross Blue Shield Medical Policy Updates »

Policy Alerts monitors Commercial and Medicare medical policies for changes. While medical Insurance carriers typically update medical policies annually, there are many reasons why they might review or update a policy. When reviews occur out of cycle they often go unnoticed. Policy Alerts keeps you updated when Payers make coverage changes to medical policies affecting your business.

Policy Alerts continuously monitors Commercial and Medicare Payer coverage information to keep you up-to-date on medical Insurance decisions in real-time. When changes occur, instant email alerts are delivered to your inbox. Clients have access to detailed coverage reports and medical policies through the interactive Policy Alerts Dashboard portal. Save time each month and keep focused on important Payer medical policy reviews and coverage decisions affecting your business!

Policy Alerts takes a client-focused hands-on approach and is constantly working to provide our customers with helpful insights and actionable analytics. We understand what our clients need and are dedicated to providing timely, accurate, and always up-to-date reports.

Health economic and reimbursement information provided by Policy Alerts is gathered from third-party sources and is subject to change without notice as a result of complex and frequently changing laws, regulations, rules and policies. All product and company names are trademarks™ or registered® trademarks of their respective holders. Use of them does not imply any affiliation with or endorsement by them. This information is presented for illustrative purposes only and does not constitute reimbursement or legal advice.